Tracking the COVID-19 vaccines: The global landscape

Tushar Yadav; Swatantra Kumar; Gourav Mishra; Shailendra K Saxena

doi:10.1080/21645515.2023.2191577

Tracking the COVID-19 vaccines: The global landscape

Hum Vaccin Immunother. 2023 Dec 31;19(1):2191577. doi: 10.1080/21645515.2023.2191577. Epub 2023 Mar 30.

Authors

Tushar Yadav¹, Swatantra Kumar^{2

3

4}, Gourav Mishra⁵, Shailendra K Saxena^{2

3

4}

Affiliations

¹ Department of Zoology, Jawaharlal Nehru Smriti Government Post Graduate College, Shujalpur, India.
² Centre for Advanced Research (CFAR), Faculty of Medicine, King George's Medical University (KGMU), Lucknow, India.
³ World Society for Virology, Northampton, MA, USA.
⁴ The Indian Virological Society, New Delhi, India.
⁵ Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, India.

Abstract

COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; VLPs: Virus like particles; WHO: World Health Organization; E: Envelope; M: Membrane; S: Spike; N: Nucleocapsid; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses; FDA: Food and Drug Administration; LNP: lipid-nanoparticle; AZD1222: ChAdOx1 nCoV-19; BNT162b2: Pfizer-BioNTech mRNA vaccine; mRNA-1273: Moderna vaccine; Ad26.COV2.S: Johnson and Johnson - Janssen's vaccine; Gam-COVID-Vac: Sputnik Vaccine; NVX-CoV2373: Novavax vaccine with Matrix-M™ adjuvant.

Keywords: COVID-19; SARS-CoV-2; clinical trials; efficacy; vaccine.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Ad26COVS1
BNT162 Vaccine
COVID-19 Vaccines*
COVID-19* / prevention & control
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
United States

Substances

COVID-19 Vaccines
ChAdOx1 nCoV-19
Ad26COVS1
BNT162 Vaccine

Grants and funding

We have not received any specific funding for this work. SK Saxena is supported by ICMR, Government of India. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.